Cryoport, Inc.
Company Information
Industry Pharmaceutical Preparations
SIC Code 2834
Entity Type operating
SEC Category Accelerated filer
State of Incorporation NV
Business Address 112 WESTWOOD PLACE, SUITE 350, BRENTWOOD, TN, 37027
Mailing Address 112 WESTWOOD PLACE, SUITE 350, BRENTWOOD, TN, 37027
Phone (949) 232-1900
Fiscal Year End 1231
EIN 880313393
Financial Overview
FY2024
$468.72M
Total Liabilities
$555.84M
Stockholders' Equity
$-0.93
EPS
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| SCHEDULE 13G/A Passive ownership amendment | February 5, 2026 | View on SEC |
| 4 Insider stock transaction report | December 12, 2025 | View on SEC |
| SCHEDULE 13G/A Passive ownership amendment | November 12, 2025 | View on SEC |
| 10-Q Quarterly financial report | November 6, 2025 | View on SEC |
| 8-K Current report of material events | November 4, 2025 | View on SEC |
| SCHEDULE 13G Passive beneficial ownership (>5%) | September 26, 2025 | View on SEC |
| 4 Insider stock transaction report | September 12, 2025 | View on SEC |
| 4 Insider stock transaction report | August 29, 2025 | View on SEC |
| 4 Insider stock transaction report | August 21, 2025 | View on SEC |
| 4 Insider stock transaction report | August 15, 2025 | View on SEC |
Insider Trading
SELL 1 insiders
1 recent transactions
View Full Insider Trading Profile
Related Companies
Companies in the same industry (SIC: 2834)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.